Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/6236| Title: | Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy | Authors: | Markelić, Milica Stancic, Ana Saksida, Tamara Grigorov, Ilijana Micanovic, Dragica Veličković, Ksenija Martinovic, Vesna Savic, Nevena Gudelj, Andjelija Otasevic, Vesna |
Keywords: | diabetes;ferroptosis;ferroptosis inhibitor;ferrostatin-1;β-cell death | Issue Date: | 3-Aug-2023 | Rank: | M21 | Publisher: | Frontiers | Project: | Serbian Science and Diaspora Collaboration Program: Knowledge Exchange Vouchers “Ferroptosis in the β-cells death: a possible strategy for diabetes treatment”, acronym: BetFeSis - Science Fund of the Republic of Serbia Project of the Ministry of Science, Technological Development and Innovation of Republic of Serbia |
Journal: | Frontiers in Endocrinology | Volume: | 14 | Start page: | 1227498 | Abstract: | Recently, the involvement of ferroptotic cell death in the reduction of β-cell mass in diabetes has been demonstrated. To elucidate the mechanisms of β-cell ferroptosis and potential antidiabetic effects of the ferroptosis inhibitor ferrostatin-1 (Fer-1) in vivo, a mouse model of type 1 diabetes (T1D) was used. |
URI: | https://biore.bio.bg.ac.rs/handle/123456789/6236 | ISSN: | 1664-2392 | DOI: | 10.3389/fendo.2023.1227498 |
| Appears in Collections: | Journal Article |
Show full item record
SCOPUSTM
Citations
4
checked on Nov 17, 2024
Page view(s)
10
checked on Nov 20, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.